A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Elderly Healthy Subjects
Clinical trial NCT03657719 · COMPLETED
Trial details
- NCT number
- NCT03657719
- Sponsor
- Green Cross Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-01
- Primary completion
- 2018-12-13
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.